Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Total revenue $ 20,551 $ 16,299
Cost of revenue 7,020 5,176
Gross profit 13,531 11,123
Research and development costs 10,894 9,281
Sales and marketing expenses 9,358 7,217
General and administrative expenses 9,611 7,999
Operating loss (16,332) (13,374)
Other income (expense):    
Other expense, net (22) (63)
Interest expense, net (81) (973)
Net loss $ (16,435) $ (14,410)
Net loss per share attributable to common stockholders:    
Basic (in usd per share) $ (0.68) $ (0.69)
Diluted (in usd per share) $ (0.68) $ (0.69)
Weighted average shares outstanding:    
Basic (in shares) 24,181,854 20,734,236
Diluted (in shares) 24,181,854 20,734,236
Product revenue    
Revenue:    
Total revenue $ 12,789 $ 11,913
Service and other revenue    
Revenue:    
Total revenue $ 7,762 $ 4,386